1. Leung K K, Barnes J, Ridgway G R, et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage, 2010, 51(4):1345-1359.
2. Chincarini A, Sensi F, Rei L, et al. Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease. Neuroimage, 2016, 125(5):834-847.
3. Coupé P, Fonov V S, Bernard C, et al. Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis. Human Brain Mapping, 2016, 36(12):4758-4770.
1. Zanigni S, Evangelisti S, Testa C, et al. White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study. Parkinsonism Relat Disord, 2017, 39:44-51.
2. Jubault T, Gagnon J F, Karama S, et al. Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage, 2011, 55(2):462-467.
1. Pitteri M, Romualdi C, Magliozzi R, et al. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler, 2017, 23(6):848-854.
2. Kim S H, Kwak K, Hyun J W, et al. Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder. European Journal of Neurology, 2016, 23(7):1165-1173.
1. Lin J J, Salamon N, Lee A D, et al. Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cerebral Cortex, 2007, 17(9):2007.
2. Liu M, Bernhardt B C, Bernasconi A, et al. Gray matter structural compromise is equally distributed in left and right temporal lobe epilepsy. Human Brain Mapping, 2015, 37(2):515-524.
3. Keller S S, Richardson M P, O'Muircheartaigh J, et al. Morphometric MRI alterations and postoperative seizure control in refractory temporal lobe epilepsy. Human Brain Mapping, 2015, 36(5):1637-1647.
1. Jones P W, Borich M R, Vavsour I, et al. Cortical thickness and metabolite concentration in chronic stroke and the relationship with motor function. Restorative Neurology & Neuroscience, 2016, 34(5):733.
2. Fotiadis P, Van R S, Van d G J, et al. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurology, 2016, 15(8):811-819.
1. Narr K L, Bilder R M, Toga A W, et al. Mapping Cortical Thickness and Gray Matter Concentration in First Episode Schizophrenia. Cerebral Cortex, 2005, 15(6):708.
2. Goldman A L, Pezawas L, Mattay V S, et al. Widespread Reductions of Cortical Thickness in Schizophrenia and Spectrum Disorders and Evidence of Heritability. Archives of General Psychiatry, 2009, 66(5):467-477.
3. Heinrichs R W, Pinnock F, Parlar M, et al. Cortical Thinning in Network-Associated Regions in Cognitively Normal and Below-Normal Range Schizophrenia. Schizophrenia Research and Treatment, 2017, 2017(1):1-7.
4. Sugranyes G, Solépadullés C, De l S E, et al. Cortical Morphology Characteristics of Young Offspring of Patients With Schizophrenia or Bipolar Disorder. Journal of the American Academy of Child & Adolescent Psychiatry,2016,56(1):79-88.
5. Neilson E, Bois C, Gibson J, et al. Effects of environmental risks and polygenic loading for schizophrenia on cortical thickness. Schizophrenia Research, 2017, 184:128-136.
6. Crossley N A, Scott J, Ellisonwright I, et al. Neuroimaging distinction between neurological and psychiatric disorders. British Journal of Psychiatry the Journal of Mental Science, 2015, 207(5):429.
1. Papmeyer M, Sussmann J E, Stewart T, et al. Prospective longitudinal study of subcortical brain volumes in individuals at high familial risk of mood disorders with or without subsequent onset of depression. Psychiatry Research Neuroimaging, 2015, 248:119-125.
2. Ahdidan J, Hviid L B, Chakravarty M M, et al. Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder. Acta Psychiatrica Scandinavica, 2011, 123(3):211.